review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Tak PP | |
Haringman JJ | |||
Ludikhuize J | |||
P2860 | cites work | Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis | Q22010731 |
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions | Q24564834 | ||
Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis | Q24633862 | ||
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8) | Q24792930 | ||
Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8 | Q24793032 | ||
International union of pharmacology. XXII. Nomenclature for chemokine receptors | Q28145705 | ||
CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 | Q28190115 | ||
Chemokines and disease | Q28200068 | ||
International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature | Q28201568 | ||
IFN-gamma-inducible T cell alpha chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-gamma and TNF-alpha | Q28203531 | ||
Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium | Q28216812 | ||
Lymphotactin: a cytokine that represents a new class of chemokine | Q28241663 | ||
Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor | Q28295922 | ||
A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
Chemokines: a new classification system and their role in immunity | Q29615663 | ||
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity | Q73092605 | ||
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients | Q73311968 | ||
CXCR3 and CCR5 ligands in rheumatoid arthritis synovium | Q73352970 | ||
Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow | Q73406513 | ||
The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats | Q73519506 | ||
Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint | Q73521731 | ||
The role of C-C chemokines and their receptors in osteoarthritis | Q73880323 | ||
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis | Q73904635 | ||
Inflammatory infiltrate and interleukin-8 expression in the synovium of psoriatic arthritis--an immunohistochemical and mRNA analysis | Q74080716 | ||
Lymphoid neogenesis in rheumatoid synovitis | Q74147962 | ||
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent | Q74165253 | ||
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis | Q74242399 | ||
Rheumatoid arthritis | Q74541001 | ||
A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses | Q74715421 | ||
Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis | Q74844694 | ||
RANTES expression and contribution to monocyte chemotaxis in arthritis | Q77359406 | ||
Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee | Q77368715 | ||
Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4 | Q77567376 | ||
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses | Q77723690 | ||
Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis | Q77738646 | ||
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis | Q77841725 | ||
Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression | Q77872967 | ||
Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues | Q78826829 | ||
Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
Chemokines | Q29616435 | ||
Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity | Q29617967 | ||
Chemokines and leukocyte traffic | Q29618886 | ||
Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production | Q32133705 | ||
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity | Q33181330 | ||
Monocyte chemoattractant protein-1. | Q33768274 | ||
Chemokines and cell migration in secondary lymphoid organs | Q33807114 | ||
Structure, function, and inhibition of chemokines | Q34110896 | ||
Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis | Q34129985 | ||
Chemokines: immunology's high impact factors | Q34139595 | ||
Chemokines as regulators of T cell differentiation. | Q34139602 | ||
Chemokines and angiogenesis | Q34239074 | ||
gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice | Q34290327 | ||
Interleukin-8 and the chemokine family. | Q34303829 | ||
Chemokines in pathology and medicine | Q34328278 | ||
Chemokines in autoimmune disease | Q34418051 | ||
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? | Q34754683 | ||
Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules | Q35052510 | ||
Abandoned therapies and unpublished trials in rheumatoid arthritis | Q35111841 | ||
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis | Q35553008 | ||
Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis | Q35746847 | ||
Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. | Q35786830 | ||
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis | Q35821357 | ||
An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model | Q36380336 | ||
Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo | Q37379361 | ||
Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model | Q37383845 | ||
Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity | Q39904117 | ||
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential | Q39907271 | ||
Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis | Q40671913 | ||
Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis | Q40739557 | ||
Mig, GRO alpha and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis | Q40758429 | ||
Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis | Q40790437 | ||
Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. | Q40856416 | ||
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation | Q40945513 | ||
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes | Q41054119 | ||
In vivo properties of monocyte chemoattractant protein-1. | Q41640087 | ||
Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells | Q41648813 | ||
Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration | Q42021031 | ||
Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines | Q42492021 | ||
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases | Q42605598 | ||
Chemokines have diverse abilities to form solid phase gradients | Q43564626 | ||
Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis | Q43607170 | ||
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes | Q43757508 | ||
AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. | Q43760150 | ||
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit | Q44223900 | ||
Role of Macrophage Inflammatory Protein-3α and Its Ligand CCR6 in Rheumatoid Arthritis | Q47973596 | ||
Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. | Q52018468 | ||
Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. | Q52022061 | ||
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. | Q52023146 | ||
The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. | Q52039719 | ||
Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. | Q53717677 | ||
Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. | Q53866765 | ||
Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis. | Q54797188 | ||
Expression of Chemokine Receptors by Lung T Cells from Normal and Asthmatic Subjects | Q55094015 | ||
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells | Q56890926 | ||
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis | Q57012210 | ||
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice | Q57019206 | ||
What can stochastic resonance do? | Q59061953 | ||
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
Inflammation and angiogenesis in osteoarthritis | Q59151152 | ||
T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor | Q60169458 | ||
Macrophage Inflammatory Protein-Iβ: A C-C Chemokine in Osteoarthritis | Q62734318 | ||
Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow | Q63916914 | ||
Synovial tissue macrophage as a source of the chemotactic cytokine IL-8 | Q68011933 | ||
Macrophage inflammatory protein 1 modulates macrophage function | Q68107144 | ||
Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma | Q70540252 | ||
Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor | Q70750038 | ||
Expression of the chemokine superfamily in rheumatoid arthritis | Q71645876 | ||
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells | Q71708739 | ||
A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro | Q71746761 | ||
The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines | Q71778731 | ||
Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines | Q72072827 | ||
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4 | Q72273786 | ||
Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes | Q72717877 | ||
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis | Q73076908 | ||
Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis | Q73090176 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
P304 | page(s) | 1186-1194 | |
P577 | publication date | 2004-04-13 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Chemokines in joint disease: the key to inflammation? | |
P478 | volume | 63 |
Q37707714 | Activation of the cholinergic anti-inflammatory system by nicotine attenuates arthritis via suppression of macrophage migration |
Q38709769 | An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium. |
Q47882479 | Anti-inflammatory Effect of DNA Polymeric Molecules in a Cell Model of Osteoarthritis. |
Q36052572 | Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. |
Q37154852 | Are there promising biologic therapies for osteoarthritis? |
Q42379102 | Association between TLR-9 gene rs187084 polymorphism and knee osteoarthritis in a Chinese population |
Q89025875 | Association between levels of synovial anti-citrullinated peptide antibodies and neutrophil response in patients with rheumatoid arthritis |
Q98735556 | Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles |
Q34236851 | CCAAT/enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β. |
Q56998904 | CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients |
Q24803773 | CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis |
Q34086970 | Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse |
Q35636896 | Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis |
Q91199065 | Chemokines in rheumatic diseases: pathogenic role and therapeutic implications |
Q36262470 | Chemokines: their role in rheumatoid arthritis |
Q45987541 | Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine. |
Q52613681 | Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment. |
Q34365089 | Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model |
Q38110963 | Emerging therapies for rheumatoid arthritis |
Q39976859 | Extended interaction of beta1 integrin subunit-deficient cells (GD25) with surfaces modified with fibronectin-derived peptides: Culture optimization, adhesion and cytokine panel studies |
Q37021518 | Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. |
Q61450662 | Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes |
Q34188481 | Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. |
Q28655057 | Genomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1 |
Q33755642 | IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis |
Q38434343 | Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis |
Q38872704 | Knee osteoarthritis: a review of management options |
Q90053778 | Long Non-coding RNA HOTTIP Promotes CCL3 Expression and Induces Cartilage Degradation by Sponging miR-455-3p |
Q33880198 | Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis |
Q52601576 | Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. |
Q36327429 | Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways |
Q36085680 | Osteoarthritis - an untreatable disease? |
Q24803862 | Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis |
Q42956746 | Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate |
Q28236498 | Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases |
Q35555485 | Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. |
Q37691824 | Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization |
Q82300321 | Serum chemokines in patients with rheumatoid arthritis treated with etanercept |
Q42420342 | Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. |
Q39431367 | Synovial tissue research: a state-of-the-art review |
Q42370432 | TGF-β1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model |
Q36150612 | Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis |
Q38961065 | Targeting the chemotactic function of CD147 reduces collagen-induced arthritis |
Q46457918 | The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis. |
Q85623878 | The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage |
Q79366300 | The effect of infliximab on chemokines in patients with rheumatoid arthritis |
Q43239473 | Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. |
Q28742993 | Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis |
Search more.